oAlert.pl
WARNING: RECALLED PRODUCT
PL EN

Egoropal

An out-of-specification result for the particle size parameter was found due to an incorrect limit at a manufacturing process stage (IPC), constituting a quality defect in batch 4201475. Potential effects: altered drug release, risk of lack of efficacy or increased adverse effects.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Egoropal
Risk Level
Critical
Manufacturer
Egis Pharmaceuticals PLC z siedzibą w Budapeszcie, Węgry
Batch Number
wszystkie serie
EAN Code
05995327188706
Recall Date
28.05.2024
View official statement

Important Information

What You Should Know

Recommendations

Do not use product from batch 4201475 (expiry 12.2024); patients should check the batch number on the packaging and, if they have this batch, return it to the pharmacy and consult a doctor if the medi...

Actions Taken

In 2023 the marketing of all Egoropal 75 mg batches was suspended; after investigation batch 4201475 was withdrawn and banned from marketing, and subsequently the suspension decision for the remaining...

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?
No. This product has been recalled due to: An out-of-specification result for the particle size parameter was found due to an incorrect limit at a manufacturing process stage (IPC), constituting a quality defect in batch 4201475. Potential effects: altered drug release, risk of lack of efficacy or increased adverse effects.
What should I do if I already bought this?
Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.
Which batches are affected?
Affected batch numbers: wszystkie serie

Related

Other Recalled Products